C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: Implications for clinical and subclinical atherosclerosis

Journal of the American College of Cardiology

Volumn 47, Issue 7, 2006, Pages 1369-1378

  Montero, Ines ^a   Orbe, Josune ^a   Varo, Nerea ^a   Beloqui, Oscar ^a   Monreal, José I ^a   Rodréguez, José A ^a   Díez, Javier ^a   Libby, Peter ^b   Páramo, José A ^a,c  

^a UNIVERSITY OF NAVARRA   (Spain)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERSTITIAL COLLAGENASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; RNA; STRESS ACTIVATED PROTEIN KINASE; STROMELYSIN 2;

ARTICLE; ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOLOCALIZATION; MAMMARY ARTERY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AORTA; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CAROTID ARTERIES; CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME INDUCTION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MAMMARY ARTERIES; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 10; METALLOENDOPEPTIDASES; MICROARRAY ANALYSIS; MIDDLE AGED; RECOMBINANT PROTEINS; STAINING AND LABELING; TISSUE INHIBITOR OF METALLOPROTEINASE-1; UMBILICAL VEINS;

EID: 33645412966     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.10.070     Document Type: Article

References (42)

1. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874
2. T.A. Pearson, G.A. Mensah, R.W. Alexander Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 107 2003 499 511
3. P.M. Ridker Clinical application of C-reactive protein for cardiovascular disease detection and prevention Circulation 107 2003 363 369
4. I. Jialal, S. Devaraj Role of C-reactive protein in the assessment of cardiovascular risk Am J Cardiol 91 2003 200 202
5. V. Pasceri, J.T. Willerson, E.T. Yeh Direct proinflammatory effect of C-reactive protein on human endothelial cells Circulation 102 2000 2165 2168
6. V. Pasceri, J. Chang, J.T. Willerson, E.T. Yeh Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs Circulation 103 2001 2531 2534
7. S. Verma, S.H. Li, M.V. Badiwala Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein Circulation 105 2002 1890 1896
8. S. Devaraj, D.Y. Xu, I. Jialal C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells implications for the metabolic syndrome and atherothrombosis Circulation 107 2003 398 404
9. S. Verma, E.T. Yeh C-reactive protein and atherothrombosis - beyond a biomarker an actual partaker of lesion formation Am J Physiol Regul Integr Comp Physiol 285 2003 1253 1256
10. S. Bhakdi, M. Torzewski, K. Paprotka Possible protective role for C-reactive protein in atherogenesis complement activation by modified lipoproteins halts before detrimental terminal sequence Circulation 109 2004 1870 1876
11. Z.S. Galis, G.K. Sukhova, M.W. Lark, P. Libby Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques J Clin Invest 94 1994 2493 2503
12. G.K. Sukhova, U. Schönbeck, E. Rabkin Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques Circulation 99 1999 2503 2509
13. J. Orbe, L. Fernandez, J.A. Rodriguez Different expression of MMPs/TIMP-1 in human atherosclerotic lesions. Relation to plaque features and vascular bed Atherosclerosis 170 2003 269 276
14. J. Orbe, C. Chorda, R. Montes, J.A. Paramo Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha Haematologica 84 1999 306 311
15. A.I. Saeed, V. Sharov, J. White TM4 a free, open-source system for microarray data management and analysis Biotechniques 34 2003 374 378
16. J.A. Paramo, J. Orbe, O. Beloqui Prothrombin fragment 1+2 is associated with carotid intima-media thickness in subjects free of clinical cardiovascular disease Stroke 35 2004 1085 1089
17. C. Liu, S. Wang, A. Deb Proapoptotic, antimigratory, antiproliferative, and antiangiogenic effects of commercial C-reactive protein on various human endothelial cell types in vitro implications of contaminating presence of sodium azide in commercial preparation Circ Res 97 2005 135 143
18. K.E. Taylor, J.C. Giddings, C.W. van den Berg C-reactive protein-induced in vitro endothelial cell activation is an artefact caused by azide and lipopolysaccharide Arterioscler Thromb Vasc Biol 25 2005 1225 1230
19. S.K. Venugopal, S. Devaraj, I. Yuhanna, P. Shaul, I. Jialal Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells Circulation 106 2002 1439 1441
20. T.N. Williams, C.X. Zhang, B.A. Game, L. He, Y. Huang C-Reactive protein stimulates MMP-1 expression in U937 histiocytes through Fc(gamma)RII and extracellular signal-regulated kinase pathway an implication of CRP involvement in plaque destabilization Arterioscler Thromb Vasc Biol 24 2004 61 66
21. G.D. Norata, F. Pellegatta, A. Hamsten, A.L. Catapano, P. Eriksson Effects of HDL3 on the expression of matrix-degrading proteases in human endothelial cells Int J Mol Med 12 2003 73 78
22. P. Libby, P. Ganz, F.J. Schoen, R.T. Lee The vascular biology of the acute coronary syndromes E.J. Topol Acute Coronary Syndromes 2nd edition 2000 Marcel Dekker New York, NY 33 57
23. R. Virmani, A.P. Burke, A. Farb, F.D. Kolodgie Pathology of the unstable plaque Prog Cardiovasc Dis 44 2002 349 356
24. L. van Tits, J. de Graaf, H. Toenhake, W. van Heerde, A. Stalenhoef C-reactive protein and annexin A5 bind to distinct sites of negatively charged phospholipids present in oxidized low-density lipoprotein Arterioscler Thromb Vasc Biol 25 2005 717 722
25. T. Khreiss, L. Jozsef, L.A. Potempa, J.G. Filep Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells Circulation 109 2004 2016 2022
26. C.H. Park, M.J. Lee, J. Ahn Heat shock-induced matrix metalloproteinase (MMP)-1 and MMP-3 are mediated through ERK and JNK activation and via an autocrine interleukin-6 loop J Invest Dermatol 123 2004 1012 1019
27. M.H. Pillinger, N. Marjanovic, S.Y. Kim Matrix metalloproteinase secretion by gastric epithelial cells is regulated by E prostaglandins and MAPKs J Biol Chem 280 2005 9973 9979
28. Q. Wang, X. Zhu, Q. Xu, X. Ding, Y.E. Chen, Q. Song Effect of C-reactive protein on gene expression in vascular endothelial cells Am J Physiol Heart Circ Physiol 288 2005 H1539 H1545
29. M. Griselli, J. Herbert, W.L. Hutchinson C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction J Exp Med 190 1999 1733 1740
30. Z.S. Galis, M. Muszynski, G.K. Sukhova, E. Simon-Morrissey, P. Libby Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions Ann N Y Acad Sci 748 1995 501 507
31. Y. Huang, L. Song, S. Wu, F. Fan, M.F. Lopes-Virella Oxidized LDL differentially regulates MMP-1 and TIMP-1 expression in vascular endothelial cells Atherosclerosis 156 2001 119 125
32. S. Blankenberg, H.J. Rupprecht, O. Poirier Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease Circulation 107 2003 1579 1585
33. M.J. Green, A.K. Gough, J. Devlin Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis Rheumatology 42 2003 83 88
34. G.B.J. Mancini, B. Dahlof, J. Diez Surrogate markers for cardiovascular disease structural markers Circulation 109 2004 IV22 IV30
35. L.M. Biasucci, G. Liuzzo, R.L. Grillo Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability Circulation 99 1999 855 860
36. M. Suleiman, D. Aronson, S.A. Reisner Admission C-reactive protein levels and 30-day mortality in patients with acute myocardial infarction Am J Med 115 2003 695 701
37. J. Torzewski, M. Torzewski, D.E. Bowyer C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries Arterioscler Thromb Vasc Biol 18 1998 1386 1392
38. A.P. Burke, R.P. Tracy, F. Kolodgie Elevated C-reactive protein values and atherosclerosis in sudden coronary death association with different pathologies Circulation 105 2002 2019 2023
39. A.M. Henney, P.R. Wakeley, M.J. Davies Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization Proc Natl Acad Sci U S A 88 1991 8154 8158
40. S.K. Venugopal, S. Devaraj, I. Jialal Macrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells potential for paracrine/autocrine effects Am J Pathol 166 2005 1265 1271
41. Z.S. Galis, J.J. Khatri Matrix metalloproteinases in vascular remodeling and atherogenesis the good, the bad, and the ugly Circ Res 90 2002 251 262
42. K. Yasojima, C. Schwab, E.G. McGeer, P.L. McGeer Generation of C-reactive protein and complement components in atherosclerotic plaques Am J Pathol 158 2001 1039 1051